Last Updated: November 13, 2026

CLINICAL TRIALS PROFILE FOR ESTRADIOL AND NORGESTIMATE

« Back to Dashboard

All Clinical Trials for ESTRADIOL AND NORGESTIMATE

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00236769 ↗	A Study of Efficacy and Safety With the Transdermal Contraceptive System.	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3	1997-11-01	The purpose of the study is to evaluate the contraceptive efficacy, safety, cycle control, and compliance with the transdermal contraceptive system.
NCT00254865 ↗	A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 1	2002-08-01	The objective of this study is to compare the levels of the hormones norelgestromin, norgestrel, and ethinyl estradiol in the bloodstream of healthy female volunteers administered ORTHO EVRAÂ® (a transdermal contraceptive patch) and CILESTÂ® (an oral contraceptive). The open-label treatment phase of the study consists of two 28-day cycles of one treatment, a washout period of 28 days, and crossover to two 28-day cycles of the other treatment.
NCT00301587 ↗	A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives	Withdrawn	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3	1969-12-31	The purpose of this study is to compare red blood cell folate levels in women who are taking oral contraceptives with or without folic acid
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ESTRADIOL AND NORGESTIMATE

Condition Name

Chart
Table

Condition Name for ESTRADIOL AND NORGESTIMATE
Intervention	Trials
Contraception	8
Female Contraception	5
Pharmacokinetics	5
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ESTRADIOL AND NORGESTIMATE
Intervention	Trials
HIV Infections	4
Hepatitis C	3
Acne Vulgaris	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ESTRADIOL AND NORGESTIMATE

Trials by Country

Map
Table

Trials by Country for ESTRADIOL AND NORGESTIMATE
Location	Trials
United States	16
Thailand	1
Egypt	1
Canada	1
New Zealand	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ESTRADIOL AND NORGESTIMATE
Location	Trials
Texas	4
Kansas	3
California	3
Washington	2
Wisconsin	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ESTRADIOL AND NORGESTIMATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ESTRADIOL AND NORGESTIMATE
Clinical Trial Phase	Trials
PHASE1	1
Phase 4	3
Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ESTRADIOL AND NORGESTIMATE
Clinical Trial Phase	Trials
Completed	24
Unknown status	3
Suspended	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ESTRADIOL AND NORGESTIMATE

Sponsor Name

Chart
Table

Sponsor Name for ESTRADIOL AND NORGESTIMATE
Sponsor	Trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	9
Bristol-Myers Squibb	5
ViiV Healthcare	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ESTRADIOL AND NORGESTIMATE
Sponsor	Trials
Industry	32
Other	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.